Skip to content

Fake chewing for the treatment of postoperative nausea and vomiting: a randomized controlled trial

Fake chewing for the treatment of postoperative nausea and vomiting: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105249
Enrollment
Unknown
Registered
2025-07-01
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nausea and vomiting

Interventions

Ondansetron group:Patients who were randomly assigned to the ondansetron group, or those who were randomly assigned to the sham chewing group but refused or were excessively drowsy, received intraveno
Fake Chewing Group:Patients who experience PONV in PACU are randomly assigned to the sham chewing group, and the observer evaluates their alertness/sedation (OAA/S) score as 5-6 ("respond immediately

Sponsors

Jiangxi Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Female patients undergoing elective general anesthetic laparoscopic surgery and breast surgery; Age 18~65 years old; ASA Class I~III; Subjects voluntarily participate in the study and sign the informed consent form for this study.

Exclusion criteria

Exclusion criteria: Those who are allergic to opioids, benzodiazepines, propofol and other narcotic drug excipients; Suspected abuse of narcotic analgesics or sedatives, as well as alcoholics; Have severe cardiac arrhythmias; History of acute respiratory infection within 2 weeks with no cure; Those with a history of severe heart, brain, lung, liver, kidney or metabolic diseases; Have a neuromuscular system disorder (e.g., myasthenia gravis); people with mental illness; Those who predict that a difficult airway may occur or have occurred, such as modified Marhalanobis class III.-IV; Pregnant or lactating females; Use of long-acting antiemetics, emetics, opioids or glucocorticoids within one week before surgery; Have other diseases that may manifest as nausea or vomiting , such as hepatitis or gastric ulcers; Contraindications to dexamethasone; impaired pharyngeal or esophageal function; Have full upper and lower dentures (unable to chew)

Design outcomes

Primary

MeasureTime frame
The degree of relief of PONV;

Secondary

MeasureTime frame
Number of nausea, retching, and vomiting;

Countries

China

Contacts

Public ContactLuo Heguo

Jiangxi Provincial People's Hospital

ddjy121@163.com+86 791 8689 6203

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026